Brief: Glenmark Pharmaceuticals Completes Divestment of Cardiac Brand In India And Nepal To J.B. Chemicals & Pharmaceuticals
Dec 21 (Reuters) - Glenmark Pharmaceuticals Ltd
GLEN.NS :
* COMPLETED TRANSACTION TO DIVEST CARDIAC BRAND, RAZEL, IN
INDIA
AND NEPAL TO J.B. CHEMICALS & PHARMACEUTICALS
Source text for Eikon: ID:nBSE43Z437
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on J B Chemicals and Pharmaceuticals
See all newsIndian drugmaker Torrent Pharma posts lower quarterly profit on acquisition costs
India's J B Chemicals and Pharmaceuticals drops after quarterly profit fall
Brief: JB Chemicals Posts March-Qtr Consol Net PAT 1.01 Billion Rupees
Morgan Stanley initiates coverage on India's Torrent Pharma, Mankind Pharma
Brief: JB Chemicals Says Narayan Saraf Resigns As CFO